[Beta-blockers, beta-stimulators and Raymaud's syndrome].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents
Beta-blokkere og beta-stimulatorer og Raynauds syndrom.